Oral glucose tolerance test values as a predictor of pharmacotherapy requirement in gestational diabetes mellitus
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background: Gestational Diabetes Mellitus (GDM) is defined as glucose intolerance that is first recognized during pregnancy. It is associated with several adverse maternal and neonatal outcomes. Early identification of women likely to require pharmacotherapy beyond Medical Nutrition Therapy (MNT) may facilitate timely intervention and improved outcomes. Objective: To evaluate whether serum glucose levels during Oral glucose Tolerance Test OGTT can predict the mode of treatment required to achieve optimal glycemic control in women with GDM. Methods: This prospective cohort study included 120 women diagnosed with GDM by OGTT using IADPSG criteria at LN Medical College, Bhopal. Participants were categorized into 4 groups based on treatment required to attain optimal glycemic targets: I) MNT only, II) MNT + Metformin, III) MNT + Insulin, or IV) MNT + Metformin & Insulin. OGTT values were compared across these groups. Results: Women in Group II(n=27) had significantly higher 1-hour OGTT values than in Group I(n=83) (198±31.3 vs. 158±23.3 mg/dL, p=0.003). Group III (n=9) demonstrated significantly higher fasting (131±16.7 vs. 106±12.2 mg/dL, p=0.007), 1-hour (222±27.8 vs. 158±23.3 mg/dL, p
Fields of Study & Subjects
Gestational Diabetes Research and Management
Pregnancy and Medication Impact
Diabetes Management and Research
Publication details
- Journal / source
- International Journal of Clinical Obstetrics and Gynaecology
- Volume
- 10
- Issue
- 2
- Pages
- 617–621
- Publication date
- 1 March 2026
- Language
- EN